Table 5.
Statistical analysis of p16 expression and clinicopathologic factors
| p16 (-) | p16 (+) | P value (χ2) | |
| Sex | |||
| Male | 12 | 18 | |
| Female | 9 | 12 | 0.838 (0.042) |
| Age (yr) | |||
| < 50 | 5 | 4 | |
| ≥ 50 | 16 | 26 | 0.334 (0.933) |
| Size (cm) | |||
| < 5 | 4 | 13 | |
| ≥ 5 | 17 | 17 | 0.070 (3.279) |
| Mitotic index | |||
| ≤ 5/50 HPF | 8 | 21 | |
| > 5/50 HPF | 13 | 9 | 0.024 (5.126) |
| Risk | |||
| Very low and low | 4 | 13 | |
| High | 12 | 8 | 0.045 (4.98) |
| Site | |||
| Stomach | 13 | 17 | |
| Intestine | 7 | 11 | |
| Other | 1 | 2 | 0.917 (0.173) |
HPF: High-power fields.